Chondrogard® is a ready solution of Chondroitin Sulfate for Intramuscular administration, whose main component is CS b-Bioactive®. It is available in two dosages (100 mg/ml and 200mg/ml injections). One course of treatment includes one injection per day during 25-30 consecutive days. If needed the course could be repeated after 6 or 12 months. The solution has a high bioavailability.
Chondrogard® is intended for the treatment of degenerative diseases of joints and the spine:
- Osteoarthritis of peripheral joints
- Spondylosis of the spine
- Promotion of callus formation after a fracture
For more detailed information, please visit: http://www.sotex.ru/production/catalog/detail.php?ELEMENT_ID=2467
Chondrogard® is manufactured by “Sotex PharmFirm” (Russia).
About Sotex PharmFirm
“Sotex PharmFirm” is one of the leading pharmaceutical manufacturers in Russia with own manufacturing plant located in the Moscow Region, is designed and operated in accordance with GMP EU requirements. Production areas: own brands and generics, licensed brands of global leaders.
The factory carries out a complete production cycle of preparation of injectable solutions, filling of ampoules and syringes, production of final presentation in prefilled syringes, packaging for solid dosage forms. All manufacturing processes are carried out in strict accordance with international requirements using the equipment of leading European corporations.
The company's product portfolio includes more than 150 demanded drugs, including major part own brands and products. Product portfolio areas: neurology, rheumatology, oncology, nephrology, cardiology, psychoneurology, etc.
Sotex has its own R&D department and is actively developing the portfolio of its own brands, increasing their number yearly.
The company also has a unique for Russia market experience of direct interaction with leading international pharmaceutical manufacturers in licensed production and promotion of medical products.
More information about Sotex PharmFirm at www.sotex.ru